Malley Thomas
- SEC CIK
- 0001403322
No open-market purchases or sales filed in the past year.
Current role at each company
- KURA Kura Oncology, Inc.Directoras of Jun 4, 2026
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Jun 2, 2026
- ONC BeOne Medicines Ltd.Directoras of Jun 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Malley Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KNSA Kiniksa Pharmaceuticals International, plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 (view filing) | Aug 12-14 | 2 days | Malley ThomasDirector | SSaleClass A Ordinary Shares | −177.8K | $32.96 | −$5.86M | −93.4%12.5K after | 3 lots |
KURA Kura Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 (view filing) | Jun 16 | 5 days | Malley ThomasDirector | PPurchase | +50.0K | $11.50 | +$575.0K | +55.8%139.6K after |